NCT01035437撤回不适用
A Pilot Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 主要终点
- Determine the toxicity of sequential PDT and chemoradiation in obstructing esophageal cancer
研究概览
简要总结
This study aim is to find out what effects capecitabine, oxaliplatin and radiation therapy following photodynamic therapy have on esophageal cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Partially or completely obstructing primary esophageal carcinoma, clinical stage I-IVa as determined by endoscopy, CT-scan, PET +/- endoscopic ultrasound. For distal esophagus tumors involving the GE junction, at least 50% or greater of the tumor bulk should be in the distal esophagus
- •Ineligible for or refused surgical resection
- •No Prior therapy allowed for esophageal cancer
- •ECOG Performance status 0-1
- •Life expectancy > 4 months
- •Adequate hematologic parameters (hemoglobin> 9g/dl, ANC > 1500/ul, Platelets > 100,000/ul)
- •Adequate biochemical parameters (total bilirubin and creatinine within institutional limits, AST and alkaline phosphatase less tham or equal to 3xUNL)
- •Age > 18 years
- •Signed informed consent
- •Bronchoscopy with biopsy and cytology if primary esophageal cancer is < 26 cm from incisors
- •Female patients of childbearing potential should have a negative serum or urine pregnancy test within 7 days prior to registration
- •Patients of Childbearing potential agree to use an effective form of contraception during the study and for 90 days following the last dose of study medication (an effective form of contraception is an oral contraceptive or a double barrier method
- •Both men and women and members of all races and ethnic are eligible for this trial
排除标准
- •Hypersensitivity to platinum compounds, fluoropyrimidines or to antiemetics appropriate for administration in conjunction with protocol-directed chemotherapy
- •Patients may not be receiving any other investigational agents
- •Patients with known brain metastases should be excluded from this trail
- •Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia or psychiatric illness/social situations that would limit compliance with study requirements
- •Peripheral neuropathy ≥ Grade 2
- •History of second malignancy within the previous years except for curatively treated carcinoma of the cervix in-situ or non-melanomatous skin cancer
- •Patients who are pregnant or lactating
- •Porphyria or hypersensitivity to porphyrin-like compounds
- •Patients with known HIV or Hepatitis B or C (active, previously treated or both)
- •Patients with tracheal or bronchial involvement, as determined by bronchoscopy
- •Patients with documented unilateral or bilateral vocal cord paralysis
- •Patients with T4 lesions by CT, MRI or EUS involving the aorta, lung or pericardium
研究组 & 干预措施
HPPH
Experimental
HPPH
干预措施: HPPH 2-1[1-hexyloxyethyl]-2-devinyl Pyropheophorbide-a) (Drug)
结局指标
主要结局
Determine the toxicity of sequential PDT and chemoradiation in obstructing esophageal cancer
时间窗: 2 year
次要结局
- Evaluate the efficacy of PDT in palliation of dysphagia(2 years)
研究者
相似试验
已完成
1 期
Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas AdenocarcinomaPancreasCancerNCT00707278University of Utah13
已完成
1 期
Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal CancerGall Bladder CancerBile Ductus CancerPancreas CancerColorectal CancerStomach CancerNCT01016639Lund University Hospital106
已完成
1 期
Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic CancerPancreatic NeoplasmsNCT00242190University of Michigan Rogel Cancer Center40
已完成
2 期
Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal CancerRectal NeoplasmsNCT00263029Sanofi18
终止
2 期
Radiation Therapy With Capecitabine in Rectal CancerRectal CancerNCT00176787University of Michigan Rogel Cancer Center30